?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 29, 2021
signalgroup
FDA’s Approval of First Interchangeable Biosimilar Product Paves Way for Lower Health Care Costs for Patients
News
July 15, 2021
signalgroup
Food & Drug Administration Takes Strong Enforcement Action Against Biosimilar Misinformation
News
July 9, 2021
signalgroup
President Biden’s Executive Order to Support Biosimilar Drugs Will Provide Lower Cost Options for Patients
News
July 8, 2021
signalgroup
Morning Consult: Expanding Access to Biosimilars Has Bipartisan Support. But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate
News
June 30, 2021
signalgroup
Biosimilars Forum Member Spotlight: 6 Questions for Coherus
News
June 24, 2021
signalgroup
Organon Joins Biosimilars Forum
News
June 21, 2021
signalgroup
Lowering Prices with Biosimilars: ASP+8: Stakeholder Meeting Round-Up
News
June 18, 2021
signalgroup
It’s time we fulfill the ACA’s promise to broaden access to lower-cost drugs
News
June 17, 2021
signalgroup
The Biosimilars Forum Applauds SCOTUS Decision to Uphold ACA and US Pathway for Biosimilar Approval
News
June 14, 2021
signalgroup
New Report Shows Biosimilars Significantly Lowered Prices of All Biologics
Prev page
05
06
07
08
09
Next page